Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chemotherapy Resistance and Sensitivity Testing in Lung Tumors

This study has suspended participant recruitment.
(lung cancer study was rolled into a broader "human subject tissue" study including lung cancer.)
Sponsor:
Collaborator:
Cabell Huntington Hospital
Information provided by (Responsible Party):
Pier Paolo Claudio, M.D., Ph.D., Marshall University
ClinicalTrials.gov Identifier:
NCT01570855
First received: March 19, 2012
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)